H|T: The Healthtech Times – Blunder drug
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…
Eli Science Inc. has raised a $1.9 million CAD ($1.5 million USD) seed round to target the historically underserved women’s…
Virtual care company Think Research is set to acquire fellow Toronto-based company MDBriefCase, for a total value of $25.3…
Three Atlantic Canada startups, PLATO, BreatheSuite, and TrojAI, have recently announced fresh funding rounds to fuel their…
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…
Following its recent debut on the TSX Venture Exchange (TSXV), Think Research, a developer of virtual care technology and clinical…
MCI Onehealth, a Toronto-based healthtech company, has closed $30 million CAD for its initial public offering (IPO). The company’s…
Three Canadian startups and one American startup with a Canadian founder have recently announced new funding to fuel their…
Three Canadian organizations have brought on new team members, including Alida, Medical Innovation Xchange, and Nuvei. Here’s…
Mississauga-based healthtech company PointClickCare has closed its acquisition of Utah-based Collective Medical, its largest…
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…
Montréal-based virtual care company EQ Care has been acquired by Telus Health, BetaKit has learned. A spokesperson for Telus…
Toronto-based digital mental health treatment startup MindBeacon has priced its initial public offering (IPO), setting the…
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…
Toronto healthtech startup Adracare is set to be acquired by WELL Health Technologies in a $4.75 million CAD deal. On January…